-
1 Comment
Zhejiang Shengda Bio-Pharm Co., Ltd is currently in a long term downtrend where the price is trading 26.5% below its 200 day moving average.
From a valuation standpoint, the stock is 54.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Zhejiang Shengda Bio-Pharm Co., Ltd's total revenue rose by 76.0% to $216M since the same quarter in the previous year.
Its net income has increased by 359.0% to $49M since the same quarter in the previous year.
Finally, its free cash flow grew by 536.7% to $129M since the same quarter in the previous year.
Based on the above factors, Zhejiang Shengda Bio-Pharm Co., Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE100002W43 |
| Market Cap | 3B |
|---|---|
| Dividend Yield | None |
| Target Price | 15.13 |
| Beta | 0.39 |
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin and natamycin; and intermediate APIs. The company is based in Tiantai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603079.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
